Homepage

Everything that a bio-entrepreneur needs, all in one location.

Learn more about Bakar Labs (2:06)

There has never been a shortage of entrepreneurs with great ideas designed to tackle the most pressing global challenges — from human health to environmental sustainability.

To grow those ideas into successful ventures, entrepreneurs need space, equipment, and multiple connections to a vibrant ecosystem. That’s why we created Bakar Bio Labs at UC Berkeley. Bakar Bio Labs is built to be the foundational hub for resources where startups thrive.

New Impact Grant recipients aim to translate their research into real world solutions

Launched in 2023, our BioEnginuity Impact Grant helps STEM doctoral students aim their research toward the greater social good. The grant offers students the flexibility to reimagine their research in interdisciplinary directions, commercialize their technology, or pursue industry partnerships, all with the goal of solving the world’s most pressing problems. Awardees are also supported by extracurricular offerings, including workshops, networking, and mentoring opportunities. Our fourth cohort of fellows has demonstrated a clear commitment to tackling global challenges through collaborative research. Read post
Root corn spore trapping devices deployed in a corn field

Spraying Fungicide to Protect the Crop in Minnesota

Root Applied Sciences has set up spore capture devices across the southern tier of Minnesota. The company developed its approach while pioneering detection and treatment for diseases that affect grapevines at vineyards. To protect their valuable produce, winemakers were spraying numerous times across a growing season. Root Applied Sciences developed a way of detecting and modeling infection that allowed those growers to cut their application in half. Read post
IGI-Bakar Labs and Bakar Labs for Energy & Materials construction site July 2026

Berkeley makes its startup pitch

The Berkeley Innovation Zone on the west side of UC Berkeley — between campus and downtown — showcases how the City of Berkeley is working with the university to welcome and support entrepreneurs, in a cultural change that could ultimately bring in more revenue. BIZ includes two incubators currently under construction: IGI-Bakar Labs and Bakar Labs for Energy & Materials. Read post
Rendering of a daytime view from the corner of Oxford Ave. and University Ave. (Credit: Weiss/Manfredi. Lead design architect: Weiss/Manfredi Architects. Executive architect: DGA.

Turner Celebrates Groundbreaking of the Innovative Genomics Institute – Bakar Labs Building

Turner Construction Company joined the University of California, Berkeley, the Innovative Genomics Institute (IGI), Bakar Labs, project partners, researchers, and community leaders to celebrate the groundbreaking of the Innovative Genomics Institute – Bakar Labs building, marking a major milestone for one of the most transformative life sciences developments in the Bay Area. The groundbreaking represents the culmination of years of vision, planning, and collaboration among UC Berkeley, the Innovative Genomics Institute, Bakar Labs, philanthropic supporters, architects Weiss/Manfredi and DGA, engineers, consultants, and construction partners working toward a shared goal: creating a world-class hub where scientific discovery, entrepreneurship, and innovation can thrive together. The project will become a cornerstone of Berkeley’s Innovation Zone and further strengthen the city’s position as a global leader in biotechnology and climate-focused research. Read post
Four men in a panel presentation sit on stage in an auditorium filled with people

Genentech-adjacent Japanese drugmaker sets up Peninsula office, looks for deals

Even if you’ve never heard of Chugai Pharmaceutical, you may have heard of some of the drugs that started there: the inflammation and autoimmune disease-fighting drug Actemra and the hemophilia drug Hemlibra, for example. Or you may recall some of its partnerships, like a pact earlier this month with age-related disease company Gero or a partnership with Eli Lilly and Co. around oral GLP-1 weight-loss drug Foundayo. Now the Japanese drugmaker — related to Swiss drugmaker Roche and its Genentech Inc. unit — is prepping for more deals and more visibility. It is setting up a U.S. partnering beachhead in South San Francisco, a three-person office focused on connecting its antibody engineering and small-molecule expertise with life sciences innovators in academia and early-stage companies. Chugai recently became an industry affiliate of Bakar Bio Labs. Read post
Bakar Labs in numbers
Powered by QB3

Built for startups. For more than 20 years, QB3 has been the University of California’s center for innovation and entrepreneurship in life science. Through pitch summits, seminars, symposia, podcasts, office hours, internships, and workshops QB3 educates, connects, and elevates the entrepreneurial ecosystem.

Learn about QB3
Decorative graphic of QB3 structure